Benefit of Ranbaxy deal to accrue in few years: Sun Pharma
It will take a "few years" for Sun Pharma to realise the benefits of its USD 4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov.
Sep 29, 2014, 16:38 PM IST
It will take a "few years" for Sun Pharma to realise the benefits of its USD 4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov.
Sep 29, 2014, 16:38 PM IST